John Hayward Eldridge

This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Wyeth Holdings Corporation, Wyeth, American Cyanamid Company. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Hayward Eldridge. Retrieved from https://idiyas.com/inventor/john-hayward-eldridge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 57.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 155(Granted Patents)

Location History:

Fairport, NY (US) (2001 - 2008)
Somers, NY (US) (2014)

Company Filing History:

4 out of 113

Wyeth Holdings Corporation

American Cyanamid Company

patents

4. 1 out of 1

The United States of America as Represented by the Uniformed Services University of the Health Sciences

patent

where one patent can have more than one assignee

Years Active: 2001-2014

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8623382 - Immunogenic compositions for inducing an immune response to HIV (2014-01-07),

2. 7384640 - Mutant cholera holotoxin as an adjuvant (2008-06-10),

3. 6841160 - Meningococcal vaccines formulated with interleukin-12 (2005-01-11),

4. 6709658 - Pneumococcal vaccines formulated with interleukin-12 (2004-03-23),

5. 6635261 - Adjuvant and vaccine compositions containing monophosphoryl lipid A (2003-10-21),

6. 6488936 - Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof (2002-12-03),

7. 6306404 - Adjuvant and vaccine compositions containing monophosphoryl lipid A (2001-10-23),

Title: John Hayward Eldridge: Innovator in Immunogenic Compositions

Introduction

John Hayward Eldridge is a notable inventor based in Fairport, NY (US). He has made significant contributions to the field of immunology, holding a total of 7 patents. His work primarily focuses on developing immunogenic compositions aimed at inducing immune responses to various pathogens.

Latest Patents

Among his latest patents, Eldridge has developed immunogenic compositions for inducing an immune response to HIV. This invention involves combinations of plasmids that express defined antigens, which may include single antigens or fusions of multiple antigens. Another significant patent involves a mutant cholera holotoxin that serves as an adjuvant. This mutant features a specific point mutation at amino acid 29 of the A subunit, enhancing the immune response to selected antigens from pathogenic organisms.

Career Highlights

Eldridge has worked with prominent companies in the pharmaceutical industry, including Wyeth Holdings Corporation and Wyeth. His experience in these organizations has contributed to his expertise in immunogenic research and development.

Collaborations

Eldridge has collaborated with notable colleagues such as Vincent James LaPosta and Randall K Holmes. These partnerships have likely enriched his research and innovation efforts.

Conclusion

John Hayward Eldridge's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of immunogenic therapies.

Profile summary based on public USPTO records.